E-DRUG: ARV Progtram Management Training- advance notice
----------------------------------------------------
To respond DO NOT CLICK REPLY.
respond to Sarah Petty at spetty@bu.edu
WHO Collaborating Center in Pharmaceutical Policy
and
Boston University School of Public Health present:
Antiretroviral Program Management Issues in Low Resource Settings:
A Training Seminar for Policy Makers & Program Managers
August 7 - August 18, 2006
Boston University School of Public Health, Boston, MA, USA
Background
Funding through Global Fund, PEPFAR, and other initiatives has recently
transformed AIDS into a treatable disease in developing and transitional
countries. Resources such as ARVs and diagnostics are now available;
however, rapid scale-up of AIDS treatment programs has not occurred, in
part, due to ARV drug management issues. ARV drug management issues include
difficulties with pharmaceutical supply systems and logistics, insufficient
human resources to provide ART, and barriers to ARV adherence.
Seminar Overview
Week One (August 7-11, 2006): Drug Management Key Issues
A description of the various national and international players involved in
ARV management will be discussed with recommendations to efficiently
coordinate efforts. Specific drug management issues to be covered include:
evidence -based selection of medications, quantification, procurement,
pricing, quality assurance, pre-qualification of suppliers and monitoring
and evaluation.
Week Two (August 14-18, 2006): ARV Adherence
An overview of adherence issues will be followed by instruction on how to
measure ARV adherence. Approaches to improve adherence to AIDS and other
chronic diseases will be presented. A field visit to an ARV adherence clinic
will allow participants an opportunity and interact with health care
practitioners (pharmacists, physicians, nurses, social workers,
nutritionists) involved in ARV adherence activities.
Who Should Attend?
Policy makers, ARV Program Managers, and NGO Officials responsible for
national and local programs. Social scientists, pharmacists, and other
public health professionals interested in ARV management and ART adherence.
Teaching Methods
Instruction will occur in English. The format will be highly interactive
with presentations by international experts followed by facilitated group
exercises and discussion. Case studies and guided readings will be provided
and substantial preparation is required for each session. A field visit to
an ARV Adherence Clinic will be arranged.
Faculty
Richard Laing, World Health Organization, Geneva; Brenda Waning, Boston
University School of Public Health; Michael Montagne, Mass. College of
Pharmacy; Libby Levison, Pharmaceutical Consultant
Fees
Conference costs (no academic credit): $1,282 USD includes tuition and
materials fee. For those who wish to obtain academic credit (2 credits) for
the course, the cost is $2,170 USD. Students wishing to take the class for
credit must already have a student visa to study in the US.
For more information or an application,
please contact Sarah Petty at spetty@bu.edu or by phone (+1) 617-638-5234